These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 27748860)

  • 41. Context-dependent signaling defines roles of BMP9 and BMP10 in embryonic and postnatal development.
    Chen H; Brady Ridgway J; Sai T; Lai J; Warming S; Chen H; Roose-Girma M; Zhang G; Shou W; Yan M
    Proc Natl Acad Sci U S A; 2013 Jul; 110(29):11887-92. PubMed ID: 23812757
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Toll-like receptor 9 ligand blocks osteoclast differentiation through induction of phosphatase.
    Amcheslavsky A; Bar-Shavit Z
    J Bone Miner Res; 2007 Aug; 22(8):1301-10. PubMed ID: 17488193
    [TBL] [Abstract][Full Text] [Related]  

  • 43. New insights into BMP9 signaling in organ fibrosis.
    Tang N; Rao S; Ying Y; Huang Y
    Eur J Pharmacol; 2020 Sep; 882():173291. PubMed ID: 32574673
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Activin A stimulates IkappaB-alpha/NFkappaB and RANK expression for osteoclast differentiation, but not AKT survival pathway in osteoclast precursors.
    Sugatani T; Alvarez UM; Hruska KA
    J Cell Biochem; 2003 Sep; 90(1):59-67. PubMed ID: 12938156
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Bone morphogenetic proteins in bone stimulate osteoclasts and osteoblasts during bone development.
    Okamoto M; Murai J; Yoshikawa H; Tsumaki N
    J Bone Miner Res; 2006 Jul; 21(7):1022-33. PubMed ID: 16813523
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [RANKL signaling and bone diseases. Quiescent osteoclast precursors and RANKL signaling].
    Mizoguchi T
    Clin Calcium; 2011 Aug; 21(8):1187-92. PubMed ID: 21814024
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Nitrogen-containing bisphosphonate, YM529/ONO-5920 (a novel minodronic acid), inhibits RANKL expression in a cultured bone marrow stromal cell line ST2.
    Nishida S; Tsubaki M; Hoshino M; Namimatsu A; Uji H; Yoshioka S; Tanimori Y; Yanae M; Iwaki M; Irimajiri K
    Biochem Biophys Res Commun; 2005 Mar; 328(1):91-7. PubMed ID: 15670755
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Epidermal growth factor receptor regulates osteoclast differentiation and survival through cross-talking with RANK signaling.
    Yi T; Lee HL; Cha JH; Ko SI; Kim HJ; Shin HI; Woo KM; Ryoo HM; Kim GS; Baek JH
    J Cell Physiol; 2008 Nov; 217(2):409-22. PubMed ID: 18543257
    [TBL] [Abstract][Full Text] [Related]  

  • 49. DU145 human prostate cancer cells express functional receptor activator of NFkappaB: new insights in the prostate cancer bone metastasis process.
    Mori K; Le Goff B; Charrier C; Battaglia S; Heymann D; Rédini F
    Bone; 2007 Apr; 40(4):981-90. PubMed ID: 17196895
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cysteine proteinase inhibitors regulate human and mouse osteoclastogenesis by interfering with RANK signaling.
    Strålberg F; Henning P; Gjertsson I; Kindlund B; Souza PP; Persson E; Abrahamson M; Kasprzykowski F; Grubb A; Lerner UH
    FASEB J; 2013 Jul; 27(7):2687-701. PubMed ID: 23572233
    [TBL] [Abstract][Full Text] [Related]  

  • 51. BMP9 and BMP10 are critical for postnatal retinal vascular remodeling.
    Ricard N; Ciais D; Levet S; Subileau M; Mallet C; Zimmers TA; Lee SJ; Bidart M; Feige JJ; Bailly S
    Blood; 2012 Jun; 119(25):6162-71. PubMed ID: 22566602
    [TBL] [Abstract][Full Text] [Related]  

  • 52. NMDA glutamate receptors are expressed by osteoclast precursors and involved in the regulation of osteoclastogenesis.
    Merle B; Itzstein C; Delmas PD; Chenu C
    J Cell Biochem; 2003 Oct; 90(2):424-36. PubMed ID: 14505357
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.
    Cao JJ; Wronski TJ; Iwaniec U; Phleger L; Kurimoto P; Boudignon B; Halloran BP
    J Bone Miner Res; 2005 Sep; 20(9):1659-68. PubMed ID: 16059637
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Bone Morphogenetic Protein 9 Regulates Early Lymphatic-Specified Endothelial Cell Expansion during Mouse Embryonic Stem Cell Differentiation.
    Subileau M; Merdzhanova G; Ciais D; Collin-Faure V; Feige JJ; Bailly S; Vittet D
    Stem Cell Reports; 2019 Jan; 12(1):98-111. PubMed ID: 30595547
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Activation of protease-activated receptor-2 leads to inhibition of osteoclast differentiation.
    Smith R; Ransjö M; Tatarczuch L; Song SJ; Pagel C; Morrison JR; Pike RN; Mackie EJ
    J Bone Miner Res; 2004 Mar; 19(3):507-16. PubMed ID: 15040840
    [TBL] [Abstract][Full Text] [Related]  

  • 56. BMP9 attenuates occurrence of venous malformation by maintaining endothelial quiescence and strengthening vessel walls via SMAD1/5/ID1/α-SMA pathway.
    Li Y; Shang Q; Li P; Yang Z; Yang J; Shi J; Ge S; Wang Y; Fan X; Jia R
    J Mol Cell Cardiol; 2020 Oct; 147():92-107. PubMed ID: 32730768
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Activin-like kinase receptor 1 (ALK1) in atherosclerotic lesions and vascular mesenchymal cells.
    Yao Y; Zebboudj AF; Torres A; Shao E; Boström K
    Cardiovasc Res; 2007 May; 74(2):279-89. PubMed ID: 17074310
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Secreted frizzled-related protein-1 inhibits RANKL-dependent osteoclast formation.
    Häusler KD; Horwood NJ; Chuman Y; Fisher JL; Ellis J; Martin TJ; Rubin JS; Gillespie MT
    J Bone Miner Res; 2004 Nov; 19(11):1873-81. PubMed ID: 15476588
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inhibition of receptor activator of nuclear factor-κB ligand (RANKL)-induced osteoclast formation by pyrroloquinoline quinine (PQQ).
    Odkhuu E; Koide N; Haque A; Tsolmongyn B; Naiki Y; Hashimoto S; Komatsu T; Yoshida T; Yokochi T
    Immunol Lett; 2012 Feb; 142(1-2):34-40. PubMed ID: 22193059
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Early induction of Hes1 by bone morphogenetic protein 9 plays a regulatory role in osteoblastic differentiation of a mesenchymal stem cell line.
    Seong CH; Chiba N; Fredy M; Kusuyama J; Ishihata K; Kibe T; Amir MS; Tada R; Ohnishi T; Nakamura N; Matsuguchi T
    J Cell Biochem; 2023 Sep; 124(9):1366-1378. PubMed ID: 37565579
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.